Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/01/24
End: 09/30/26
Due: 09/30/27
Phase: N/A
Priority: Normal
Start: 01/01/24
End: 12/31/28
Due: 12/31/29
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Ustekinumab With Semi-EN vs Exclusive EN for Preoperative Crohn's Disease Optimization. | NCT06912815 | Xiang Gao | user2@example.com | None | 2024-08-01 | 2026-09-30 | 2027-09-30 | - | - | 2025-07-14 |
| Efficacy and Safety of Upadacitinib in Inflammatory Bowel Disease | NCT06780683 | Xiang Gao | user2@example.com | None | 2024-01-01 | 2028-12-31 | 2029-12-31 | - | - | 2025-07-14 |